作者:Brian J. Groendyke、Chelsea E. Powell、Frederic Feru、Thomas W. Gero、Zhengnian Li、Hilary Szabo、Kevin Pang、John Feutrill、Bailing Chen、Bin Li、Nathanael S. Gray、David A. Scott
DOI:10.1016/j.bmcl.2020.126948
日期:2020.2
The SAR of a series of benzopyrimidodiazepinone inhibitors of TNK2 was developed, starting from the potent and selective compound XMD8-87. A diverse set of anilines was introduced in an effort to improve the in vivo PK profile and minimize the risk of quinone diimine formation.